Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older

INTRODUCTION: The incidence of herpes zoster (HZ) rises steeply after the age of 50 years and the number of HZ cases and complications such as postherpetic neuralgia (PHN) is predicted to increase because of the ageing population. The objective of this study was to estimate the cost-effectiveness of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Dermatol Ther (Heidelb)
Auteurs principaux: Shiragami, Makoto, Mizukami, Akiko, Kaise, Toshihiko, Curran, Desmond, Van Oorschot, Desiree, Bracke, Benjamin, Watanabe, Daisuke
Format: Artigo
Langue:Inglês
Publié: Springer Healthcare 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6522608/
https://ncbi.nlm.nih.gov/pubmed/30929219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-019-0291-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires